登录后查看消息通知
搜索
常见问题
消息
登录
首页
/
数据集
/
Withdrawn orphan drug designations.
Withdrawn orphan drug designations.
收藏
Figshare
2020-04-08 更新
2026-04-28 收录
孤儿药指定撤回
罕见病药物监管
数据链接:
https://figshare.com/articles/dataset/Withdrawn_orphan_drug_designations_/12100416
数据链接
链接失效反馈
官方服务:
问题咨询
购买咨询
在线客服
NEW
资源简介:
Reasons for and time of withdrawal were not specified in the FDA database.
应用场景:
创建时间:
2020-04-08
相关数据集
Table1_Licensing of Orphan Medicinal Products—Use of Real-World Data and Other External Data on Efficacy Aspects in Marketing Authorization Applications Concluded at the European Medicines Agency Between 2019 and 2021.XLSX
罕见病药物监管
真实世界数据应用
Background: Reference to so-called real-world data is more often made in marketing authorization applications for medicines intended to diagnose, prevent or treat rare diseases compared to more common
NIAID Data Ecosystem
2
0
Number of orphan designations accepted in the U.S. 2003-2025
孤儿药认定
罕见病药物监管
Annual number of accepted orphan designations in the United States from 2003 to 2025
Statista
0
0
Additional file 1: of Investigating the landscape of US orphan product approvals
孤儿药审批
罕见病药物监管
Appendix: Approved Orphan Products Dataset. (XLSX 92Â kb)
Figshare
2018-10-23 更新
1
0
© 2023-2026 上海数据发展科技有限责任公司 版权所有
沪ICP备17003045号-15
沪公网安备31010402336585号
热门搜索
社区交流群
科研交流群
商业服务
数据资源
寻源服务
数据采集
标注服务
数据产品
代理销售
数据领域
凭证登记
数据产品
介绍推广